Immunome, Inc.
IMNM
$18.17
-$0.22-1.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 582.69M | 653.48M | 272.64M | 268.04M | 317.32M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.62M | 7.30M | 7.29M | 9.40M | 5.81M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 594.31M | 660.78M | 279.92M | 277.43M | 323.13M |
|
|
|||||
| Total Current Assets | 594.31M | 660.78M | 279.92M | 277.43M | 323.13M |
| Net Property, Plant & Equipment | 19.91M | 17.61M | 14.69M | 14.29M | 15.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.57M | 4.80M | 4.77M | 4.56M | 4.45M |
| Total Assets | 619.79M | 683.19M | 299.38M | 296.29M | 342.69M |
|
|
|||||
| Total Accounts Payable | 5.53M | 3.34M | 6.15M | 4.66M | 9.13M |
| Total Accrued Expenses | 18.70M | 38.03M | 23.56M | 17.05M | 16.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.18M | 3.63M | 1.74M | 1.17M | 5.23M |
| Total Other Current Liabilities | 3.18M | 3.63M | 1.74M | 1.17M | 5.23M |
| Total Current Liabilities | 27.41M | 44.99M | 31.45M | 22.88M | 30.80M |
|
|
|||||
| Total Current Liabilities | 27.41M | 44.99M | 31.45M | 22.88M | 30.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.69M | 3.86M | 4.01M | 4.14M | 4.77M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.11M | 48.85M | 35.46M | 27.02M | 35.57M |
|
|
|||||
| Common Stock & APIC | 1.37B | 1.36B | 922.18M | 870.10M | 864.54M |
| Retained Earnings | -782.00M | -728.16M | -658.26M | -600.81M | -557.41M |
| Treasury Stock & Other | -- | -- | -- | -24.00K | -3.00K |
| Total Common Equity | 588.69M | 634.34M | 263.92M | 269.27M | 307.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 588.69M | 634.34M | 263.92M | 269.27M | 307.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 588.69M | 634.34M | 263.92M | 269.27M | 307.13M |
|
|
|||||